[go: up one dir, main page]

RU2000114174A - APPLICATION OF PHOSPHOLIPID COMPLEXES OF EXTRACTS FROM VITIS VINIFERA AS ANTIATHEROSCLEROTIC AGENTS - Google Patents

APPLICATION OF PHOSPHOLIPID COMPLEXES OF EXTRACTS FROM VITIS VINIFERA AS ANTIATHEROSCLEROTIC AGENTS

Info

Publication number
RU2000114174A
RU2000114174A RU2000114174/14A RU2000114174A RU2000114174A RU 2000114174 A RU2000114174 A RU 2000114174A RU 2000114174/14 A RU2000114174/14 A RU 2000114174/14A RU 2000114174 A RU2000114174 A RU 2000114174A RU 2000114174 A RU2000114174 A RU 2000114174A
Authority
RU
Russia
Prior art keywords
vitis vinifera
extracts
application
drug
use according
Prior art date
Application number
RU2000114174/14A
Other languages
Russian (ru)
Other versions
RU2207866C2 (en
Inventor
Паоло МОРАЦЦОНИ
Эцио БОМБАРДЕЛЛИ
Original Assignee
Индена С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT97MI002690A external-priority patent/IT1296920B1/en
Application filed by Индена С.П.А. filed Critical Индена С.П.А.
Publication of RU2000114174A publication Critical patent/RU2000114174A/en
Application granted granted Critical
Publication of RU2207866C2 publication Critical patent/RU2207866C2/en

Links

Claims (5)

1. Применение фосфолипидных комплексов олигомерных проантоцианидинов, содержащих от 2 до 7 катехиновых единиц, экстранированных из Vitis vinifera, для приготовления лекарственных средств для лечебной и профилактической терапии атеросклероза и инфаркта миокарда и инфаркта мозга.1. The use of phospholipid complexes of oligomeric proanthocyanidins containing from 2 to 7 catechin units extracted from Vitis vinifera for the preparation of medicines for the therapeutic and prophylactic therapy of atherosclerosis and myocardial infarction and cerebral infarction. 2. Применение по п. 1, отличающееся тем, что однократная доза лекарственного средства колеблется от 50 до 500 мг активного ингредиента. 2. The use according to claim 1, characterized in that a single dose of the drug ranges from 50 to 500 mg of the active ingredient. 3. Применение по п. 1 или 2, отличающееся тем, что лекарственное средство вводят перорально. 3. The use according to claim 1 or 2, characterized in that the drug is administered orally. 4. Применение по п. 3, отличающееся тем, что лекарственное средство находится в форме мягких или твердых желатиновых капсул или таблеток. 4. The use according to claim 3, characterized in that the drug is in the form of soft or hard gelatin capsules or tablets. 5. Способ лечения атеросклероза и инфактов микарда и мозга, который включает в себя введение пациенту эффективного количества фосфолипидного комплекса экстракта из Vitis vinifera. 5. A method for the treatment of atherosclerosis and mycardial and cerebral infarction, which comprises administering to the patient an effective amount of a phospholipid complex of the extract of Vitis vinifera.
RU2000114174/14A 1997-12-04 1998-11-30 Application of phospholipid complex extracts from vitis vinifera as antiatherosclerotic agents RU2207866C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI97A002690 1997-12-04
IT97MI002690A IT1296920B1 (en) 1997-12-04 1997-12-04 USE OF VITIS VINIFERA EXTRACT COMPLEXES WITH PHOSPHOLIPIDS AS ANTI-ATHEROSCLEROTIC AGENTS

Publications (2)

Publication Number Publication Date
RU2000114174A true RU2000114174A (en) 2002-06-27
RU2207866C2 RU2207866C2 (en) 2003-07-10

Family

ID=11378312

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2000114174/14A RU2207866C2 (en) 1997-12-04 1998-11-30 Application of phospholipid complex extracts from vitis vinifera as antiatherosclerotic agents

Country Status (22)

Country Link
US (1) US6297218B1 (en)
EP (1) EP1035859B1 (en)
JP (1) JP4456267B2 (en)
KR (1) KR100567867B1 (en)
CN (1) CN1126564C (en)
AT (1) ATE258802T1 (en)
AU (1) AU743031B2 (en)
BR (1) BR9805813B1 (en)
CA (1) CA2312795C (en)
CZ (1) CZ299555B6 (en)
DE (1) DE69821524T2 (en)
DK (1) DK1035859T3 (en)
ES (1) ES2214755T3 (en)
HU (1) HU228109B1 (en)
IT (1) IT1296920B1 (en)
NO (1) NO324796B1 (en)
PL (1) PL191023B1 (en)
PT (1) PT1035859E (en)
RU (1) RU2207866C2 (en)
SI (1) SI1035859T1 (en)
SK (1) SK284865B6 (en)
WO (1) WO1999029331A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1304183B1 (en) * 1998-12-18 2001-03-08 Indena Spa PROANTOCYANIDINE A2 COMPLEXES WITH PHOSPHOLIPIDES AS AGENTIANTIATEROSCLEROTICI.
JP2001122791A (en) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh Meal enhancer comprising aqueous extract of red vine leaf for alleviation and prophylaxis of chronic venous insufficiency in lower extremity
JP4574788B2 (en) 2000-03-24 2010-11-04 協和発酵バイオ株式会社 Proanthocyanidin-containing composition
IT1320080B1 (en) * 2000-10-25 2003-11-18 Giuliani Spa COMPOSITION FOR PHARMACEUTICAL OR DIETARY USE.
FR2836337B1 (en) * 2002-02-28 2004-11-19 Bio Serae Laboratoires USE OF PROCYANIDOLIC POLYMERS AS ALPHA-AMYLASE INHIBITOR AGENTS AND APPLICATION IN COMPOSITIONS FOR DIETETIC PURPOSES
JP4989071B2 (en) * 2002-12-31 2012-08-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Film-coated tablets containing red grape leaf extract
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
ITMI20031313A1 (en) * 2003-06-27 2004-12-28 Indena Spa ASSOCIATIONS OF VASOPROTECTOR AGENTS AND FORMULATIONS CONTAINING THEM.
EP1550450A1 (en) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Composition comprising an aqueous extract of red vine leaves and a blood circulating-improving agent for the treatment of chronic venous insufficiencies
JP2007523110A (en) 2004-02-19 2007-08-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Composition for treating chronic venous disease comprising red grape leaf extract and anti-inflammatory agent
US20060088617A1 (en) * 2004-10-23 2006-04-27 Mccurry James M Chocolate composition and method for benefiting the cardiovascular system
AT501682A1 (en) 2005-01-14 2006-10-15 Hermine Dr Engl METHOD FOR PRODUCING AN ACTIVE SUBSTANCE MIXTURE
EP1837030A1 (en) 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability
RU2314118C1 (en) * 2006-08-08 2008-01-10 Майя Отаровна Везиришвили Method for preparing extracts possessing antioxidant activity from cultivated grape compound fruit racemes
EP2829277A1 (en) 2013-07-26 2015-01-28 Natac Biotech, S.L. Use of a-type proanthocyanidins in treating a mineralocorticoid receptor related disease
EP3703724A1 (en) 2017-11-02 2020-09-09 NatureCeuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092743A1 (en) * 1970-06-15 1972-01-28 Aquitaine Invest Pharma Complete extraction of total flavanol gomers from plats -peripheral - venous activity
GB1541469A (en) * 1976-12-01 1979-02-28 Inverni Della Beffa Spa Method of obtaining flavonolic oligomers
IT1201151B (en) * 1987-01-14 1989-01-27 Indena Spa PHOSPHOLIPID COMPLEXES WITH EXTRACTS FROM VITIS VINIFERA, PROCEDURE FOR THEIR PREPARATION AND COMPOSITIONS THAT CONTAIN THEM
US5484594A (en) * 1988-06-28 1996-01-16 Tecnofarmaci S.P.A. Process for preparing grapeseed extracts enriched in procyanidol oligomers
FI955691A7 (en) 1994-11-28 1996-05-29 Suntory Ltd Lipoprotein(a)-lowering agent, cholesterol-lowering agent and medicines containing these agents

Similar Documents

Publication Publication Date Title
RU2000114174A (en) APPLICATION OF PHOSPHOLIPID COMPLEXES OF EXTRACTS FROM VITIS VINIFERA AS ANTIATHEROSCLEROTIC AGENTS
US6841544B2 (en) Composition and method for treating the effects of diseases and maladies
RU2178660C2 (en) "milona" curative-sanitation food biologically active additive and method for its obtaining
US6787164B2 (en) Composition and method for treating the effects of diseases and maladies
US20020004078A1 (en) Composition and method for treating the effects of diseases and maladies
US6576267B2 (en) Composition and method for treating the effects of diseases and maladies
BR9909672A (en) use of an active medicinal compound in the preparation of a medicament for the treatment of hypertension
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
RU2003121768A (en) METHOD, MEDICINAL FORM AND KITS FOR INCREASING ORAL BIOLOGICAL ACCESSIBILITY OF PHARMACEUTICAL AGENTS
RU2003126257A (en) A SOLID DOSED MEDICINAL FORM FOR ORAL ADMINISTRATION CONTAINING A COMBINATION OF METFORMINE AND GLYBENCLAMIDE
EP1648484B1 (en) Formulations for the treatment of arhritis conditions
US20010044411A1 (en) Composition and method for treating the effects of diseases and maladies
KR970061244A (en) Pharmaceutical composition for treating dementia
RU95101385A (en) Products containing g-csf and tnf-binding protein
JP3018160B2 (en) Drug for reducing dysmenorrhea and / or premenstrual syndrome
RU2003122061A (en) ANTIATEROSCLEROTIC COMPOSITION CONTAINING CAROTINOIDS AND METHOD FOR INHIBITING OXIDATION OF LOW DENSITY Lipoprotein (LDL)
AR035946A1 (en) PHARMACEUTICAL COMPOSITIONS TO USE IN THE TREATMENT OF DISORDERS IN WOMEN PERIMENOPAUSIC, MENOPAUSIC OR POSMENOPAUSIC, AND USES OF SUCH COMPOSITIONS FOR THE PREPARATION OF MEDICINES
US20020034555A1 (en) Composition and method for treating the effects of diseases and maladies
WO2002102308A3 (en) Pharmaceutical composition for the treatment of viral infection
JPH05201861A (en) Enhancement of antitussive effect of dextromethorphan
CA2368352A1 (en) Method for treating neurodegeneration
RU2003100081A (en) METHODS AND COMPOSITIONS IN WHICH SULODEXIDE IS USED FOR THE TREATMENT OF DIABETIC NEPHROPATHY
RU2007116726A (en) APPLICATION OF LAVENDER OIL FOR PREVENTION AND TREATMENT OF NEURASTICITY, SOMATIC DISORDERS AND OTHER DISEASES CONNECTED WITH STRESS
PL371551A1 (en) Statin therapy for enhancing cognitive maintenance
CZ79593A3 (en) Antitussive preparation